top of page

OUR COMMITTEES

About_Committee_COL.jpg

The different Committees will play an essential part in the selection of the speakers for the congress. They will also have a direct implication on the abstract selection.

The chairs are nominated by the ESGCT board and it is up to the chairs to decide who should sit on their committee, one of the committee members should be from the US or non-European continents, and another one from the co-organising National Society, this person would change every year. 

SW4_9440-e1574801777298-2_edited.jpg

AAV & non integrative vectors

IMG_1623 copy_edited.jpg

Accessibility of gene therapy

News_edited.jpg

Bleeding
disorders

51046489577_b657bdb86f_o_edited.jpg

Cardiovascular & muscular diseases

51046489577_b657bdb86f_o_edited.jpg

CNS & sensory diseases

SW4_9440-e1574801777298-2_edited.jpg

Disease models, IPS cells & organoids

IMG_1623 copy_edited.jpg

Gene
editing

News_edited.jpg

Hematopoietic diseases & PID

51046489577_b657bdb86f_o_edited.jpg

Immune responses to gene therapy

51046489577_b657bdb86f_o_edited.jpg

Immunotherapy & CART cells

SW4_9440-e1574801777298-2_edited.jpg

Infectious diseases & vaccines

IMG_1623 copy_edited.jpg

Lentiviral & integrative vectors

News_edited.jpg

Manufacturing

51046489577_b657bdb86f_o_edited.jpg

Metabolic
diseases

51046489577_b657bdb86f_o_edited.jpg

Non viral vectors | Nano-technology | RNA therapeutics 

IMG_1623 copy_edited.jpg

Oncolytic & cancer gene therapy

SW4_9440-e1574801777298-2_edited.jpg

Skin, pulmonary & skeletal diseases

News_edited.jpg

Regulatory

bottom of page